Cargando…

Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease

The relationship between changes in body components and the risk of nonalcoholic fatty liver disease (NAFLD) is not fully understood. We investigated the effects of body components and subsequent changes on incident NAFLD at follow-up ultrasound scanning in a longitudinal cohort. We included 9967 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hwi Young, Baik, Su Jung, Lee, Hye Ah, Lee, Byoung Kwon, Lee, Hye Sun, Kim, Tae Hun, Yoo, Kwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567080/ https://www.ncbi.nlm.nih.gov/pubmed/33060775 http://dx.doi.org/10.1038/s41598-020-74659-9

Ejemplares similares

Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease
por: Choe, A Reum, et al.
Publicado: (2020)

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
por: Song, Wolhwa, et al.
Publicado: (2023)

Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
por: Lee, Han Ah, et al.
Publicado: (2023)

Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
por: Yun, Yeojun, et al.
Publicado: (2019)

Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease
por: Lee, Eun Hye, et al.
Publicado: (2021)

High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia
por: Han, Eugene, et al.
Publicado: (2023)

Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
por: Lee, Han Ah, et al.
Publicado: (2023)

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
por: Kang, Seong Hee, et al.
Publicado: (2021)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
por: Nam, Ga Eun, et al.
Publicado: (2018)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
por: Kim, Yumi, et al.
Publicado: (2021)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
por: Kim, Hwi Young, et al.
Publicado: (2023)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
por: Han, Eugene, et al.
Publicado: (2021)

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease
por: Choi, Hae Yoon, et al.
Publicado: (2013)

Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2021)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Recent advances in nonalcoholic fatty liver disease metabolomics
por: Kim, Hwi Young
Publicado: (2021)

The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review
por: Kim, Hye Young, et al.
Publicado: (2022)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma
por: Jung, So Yoon, et al.
Publicado: (2017)

Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation
por: Lee, Da Eun, et al.
Publicado: (2019)

Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults
por: Seo, Ji A., et al.
Publicado: (2013)

Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study
por: Koo, Dae-Jeong, et al.
Publicado: (2021)

Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum
por: Lee, Na Young, et al.
Publicado: (2020)

Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model
por: Im, Hwi-Jin, et al.
Publicado: (2020)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
por: Lee, Sang Bae, et al.
Publicado: (2019)

A novel role of CRTC2 in promoting nonalcoholic fatty liver disease
por: Han, Hye-Sook, et al.
Publicado: (2021)

Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
por: Ye, Byoung Seok
Publicado: (2022)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease()
por: Hong, Meegun, et al.
Publicado: (2016)

The association of pericardial fat and peri-aortic fat with severity of nonalcoholic fatty liver disease
por: Lee, Chun-Wei, et al.
Publicado: (2022)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII
por: Song, Eyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3pqpr3pgmbhdndsik8eod7hri0